Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 6:13 pm Purchase | 2026-02-02 | 13G | Pliant Therapeutics, Inc. PLRX | Citadel Advisors LLC | 3,042,133 5.000% | 4,438 (+0.15%) | Filing History |
| 2026-01-30 7:11 pm Purchase | 2026-01-23 | 13G | Pliant Therapeutics, Inc. PLRX | Citadel Advisors LLC | 3,037,695 4.900% | 45,780 (+1.53%) | Filing History |
| 2026-01-23 6:59 pm Purchase | 2026-01-15 | 13G | BriaCell Therapeutics Corp. BCTX | Citadel Advisors LLC | 717,198 9.990% | 717,198 (New Position) | Filing History |
| 2026-01-22 7:02 pm Purchase | 2026-01-14 | 13G | Pliant Therapeutics, Inc. PLRX | Citadel Advisors LLC | 2,991,915 4.900% | 2,991,915 (New Position) | Filing History |
| 2026-01-21 6:20 pm Purchase | 2026-01-13 | 13G | Offerpad Solutions Inc. OPAD | Citadel Advisors LLC | 1,971,885 4.200% | 1,971,885 (New Position) | Filing History |
| 2026-01-20 6:53 pm Purchase | 2026-01-12 | 13G | Atlas Technical Consultants, Inc. ATCX | Citadel Advisors LLC | 298,520 6.000% | 298,520 (New Position) | Filing History |
| 2025-12-15 5:03 pm Purchase | 2025-12-08 | 13G | Atlas Lithium Corporation ATLX | Citadel Advisors LLC | 1,557,881 5.900% | 1,557,881 (New Position) | Filing History |
| 2025-12-04 6:35 pm Purchase | 2025-11-26 | 13G | Boundless Bio, Inc. BOLD | Citadel Advisors LLC | 1,433,388 6.400% | 1,433,388 (New Position) | Filing History |
| 2025-11-21 5:36 pm Purchase | 2025-11-14 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Citadel Advisors LLC | 1,721,867 5.500% | 180,502 (+11.71%) | Filing History |
| 2025-11-14 4:10 pm Purchase | 2025-09-30 | 13G | Strive, Inc. ASST | Citadel Advisors LLC | 41,446,863 9.990% | 41,446,863 (New Position) | Filing History |
| 2025-11-14 4:09 pm Sale | 2025-09-30 | 13G | Cabaletta Bio, Inc. CABA | Citadel Advisors LLC | 3,150,275 3.400% | -1,668,285 (-34.62%) | Filing History |
| 2025-11-14 4:09 pm Purchase | 2025-09-30 | 13G | BridgeBio Oncology Therapeutics Inc. BBOT | Citadel Advisors LLC | 2,538,142 3.200% | 2,538,142 (New Position) | Filing History |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | Bakkt Holdings, Inc. BKKT | Citadel Advisors LLC | 425,943 2.700% | -893,417 (-67.72%) | Filing History |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | Arvinas, Inc. ARVN | Citadel Advisors LLC | 264,243 0.400% | -3,215,882 (-92.41%) | Filing History |
| 2025-11-14 4:07 pm Sale | 2025-09-30 | 13G | Alignment Healthcare, Inc. ALHC | Citadel Advisors LLC | 6,718,007 3.400% | -3,790,052 (-36.07%) | Filing History |
| 2025-11-14 4:07 pm Sale | 2025-09-30 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Citadel Advisors LLC | 1,541,365 4.900% | -354,253 (-18.69%) | Filing History |
| 2025-11-14 4:06 pm Sale | 2025-09-30 | 13G | VYNE Therapeutics Inc. VYNE | Citadel Advisors LLC | 3,732 0.000% | -1,096,597 (-99.66%) | Filing History |
| 2025-11-14 4:05 pm Sale | 2025-09-30 | 13G | Safe Pro Group Inc. Common Stock SPAI | Citadel Advisors LLC | 1,311,322 6.700% | -190,391 (-12.68%) | Filing History |
| 2025-11-14 4:05 pm Sale | 2025-09-30 | 13G | Nkarta, Inc. NKTX | Citadel Advisors LLC | 2,900,358 4.100% | -919,509 (-24.07%) | Filing History |
| 2025-11-14 4:04 pm Purchase | 2025-09-30 | 13G | NioCorp Developments Ltd. NB | Citadel Advisors LLC | 7,951,251 8.200% | 4,047,856 (+103.70%) | Filing History |